Craig Venter: 'We Have Learned Nothing from the Genome'
spiegel.de
spiegel.de
Spiegel interview 2010:
SPIEGEL: The genome project has been called the Manhattan Project or Moon Landing of its era. It has also been said that knowledge of the genes will change the future of humanity and become a "main driver of the world economy."
Venter: Who said that? I didn't. That was the people at the consortium.
SPIEGEL: You're wrong. You made all those statements in an interview with DER SPIEGEL in 1998.
Venter: Really? Those are Francis Collins' lines. So I may have said that that's how he describes it. I, on the other hand, have always said, "This is a race from the starting line to the finish."
Spiegel interview 1998 (translated to German by Spiegel and back to English with Google Translate[1]):
SPIEGEL: What does the knowledge of the genetic material?
Venter: The End of Ignorance, a completely new understanding of the human body and a revolution in medicine. What we plan is there, of the order of the Manhattan Project or the moon flights. The decoding of the genome will change the self-image of humanity.
[1] http://translate.googleusercontent.com/translate_c?hl=en&...
http://www.amazon.co.uk/Backroom-Boys-Secret-Return-British/...
Venter also wanted to patent the whole human genome once he'd sequenced it. It was only by a huge and expensive effort by the Wellcome charity that the genome was sequenced and made freely available. If you enjoy reading ..AGAAACCATCAGCACA.. then:
http://www.gutenberg.org/etext/3501
This is also discussed in the Wikipedia page:
http://en.wikipedia.org/wiki/Human_Genome_Project
Anyway, the book I linked to is great fun.
Not only Wellcome (although their Sanger Centre was a major player), but a whole worldwide bucket of public money.
It also bears mentioning too that on March 14, 2000 Bill Clinton and Tony Blair issued a joint statement saying that the results of genomic sequencing shouldn't be patented. The biotech sector lost $40bn in value as a result[1], as it became evident the patent business model was dead.
[1]http://books.google.com/books?id=FOk3LE70l1EC&lpg=PA284&...
The part that reflects poorly, IMO, is how he tries to pin it on Collins when faced with the quotes. I can understand why the interviewers didn't press the issue, but I would have liked to see them press it.
SPIEGEL: How much money do you think the human genome is worth?
Venter: In any case, a lot. Each of the major pharmaceutical companies is constantly working on 50-60 new drugs. If only a part of the future knowledge of the human genome based on, then this alone brings hundreds of billions of dollars in the next decade. The knowledge of the human genes is one of the strongest drivers of the global economy.
There is broad agreement (perhaps "universal - 1") that Venter's sequencing approach would never have been able to achieve the level of completeness that we have now thanks to the Human Genome Project. This is because of duplicate DNA in the human genome, and the nature of short read lengths.
Let's try this with colors. Say you have a terrible sequencer that only reads 7bp at a time, max. You come across the following 2 strands of DNA:
GREENgattacaGREEN
REDgattacaRED
They're on 2 entirely different chromosomes, but you don't know this since there exists no reference sequence - you're mapping de novo, remember? Good. So you're get readouts like "GREENgattac" and "gattaca" and "attacaRED" - but you don't have any reads >7bp, so you never see what is on both sides of gattaca at once.
Thus, since you can never span gattaca, you will never know if your DNA in this region should be GREENgattacaRED + REDgattacaGREEN, or REDgattacaRED + GREENgattacaGREEN. For de novo alignment with short reads, this type of shortcoming is deadly.
Because the public consortium / Human Genome Project used much longer read lengths and a method involving bacterial artificial chromosomes, they were able to map the more difficult regions of the genome having repeats.
Edit I should have addressed the public consortium's approach more thoroughly, though to be clear I am less familiar with the approach and have never used it myself. Essentially, you chop up the 3 gigabase genome into a bunch of 150 kilobase segments (in this case, bacterial artificial chromosomes). You can map these back to their source chromosomes, of which we already knew we had 23. You then chop these BACs up into smaller pieces and sequence. In the worst case, you might be unsure of where some of your reads from each BAC map within the 150kb window that they come from, but hey, at least you know which chromosome and more or less which portion of the chromosome they come from. In other words, in the situation described above, the RED and the GREEN never co-occur, since they are on different BACs and are not sequenced together. Thus you know that RED/RED and GREEN/GREEN are the right pairings (and you know which belongs on which chromosome).
This doesn't invalidate anything you're saying, because finishing is important, but the whole trend towards short reads and pushing more of the job to the computer was begun by Celera. Eugene Myers is/was an amazing computer scientist, and the public project would never have finished as quickly without the push from Celera.
[beat]
Also, all of this really deals with the technical aspects of obtaining a sequence, which is not really what Venter is talking about. He's saying that a good sequence isn't that useful! I'm not sure what he means with this, or whether he's just trying to be controversial.
It is true that my post is somewhat off topic, too; I didn't want to dwell on Venter's naysaying.
Can you say a word or two about the current view of short reads for re-sequencing? I worked for a time on software for a particular lab to do alignment of short(-ish) reads like 13-bp+gap-of-100-200+7bp+gap-of-5-8+7bp+gap-of-100-200+13-bp. The idea was that you give me millions or more of those reads, and a reference like the human genome, and I give you back all of the alignments including partial matches (a few bp off, here and there).
Interesting programming problem. This aren't the actual bp counts and gap sizes I was working with - they were in that range. I got concerned that the reads we were working with were too ambiguous -- similar to the problem you describe with de novo. I was having trouble doing the combinatorics to prove myself wrong and started asking: hey, where's the mathematical analysis that shows reads of this size can possibly work? Nobody could produce it and this led to some internal strife.
That was a few years back. What's current thinking on what kind of reads plausibly work for re-sequencing? (If you happen to know. And where can I read something about the math that proves it.)
I don't have all the exact numbers handy, but 76bp will uniquely map about 80-90% of potential reads, just with single ends. A high proportion of reads can be mapped uniquely even down to 25 or 30bp. There are some 'mappability' tracks available in the UCSC browser if you're curious about a particular region.
http://hgdownload.cse.ucsc.edu/goldenPath/hg18/encodeDCC/wgE...
Of course there are repetitive and low complexity regions that can't be sequenced at all with these read lengths, or which haven't yet been properly sequenced or assembled at all even with much longer reads.
I'm not aware of a paper that has fully explicated how read-length and the structure of the reads affects mappability (especially with pairs or reads with multiple gaps), though it's certainly something that all the people building the instruments (and the mapping algorithms) have thought about a quite a lot.
Heng Li wrote BWA based on this, and it seems to handle some of the issues you were wondering about.
I would love to see if it were possible for both their egos to be occupy the same portion of space-time for longer than 20 attoseconds.
Looking at it on a programming perspective, it seems that we have a large pile of "source code" and we are still evaluating some functions (or even at some variable name) without grasping the overall modus of operation. When we are doing binary reverse engineering, we are always looking for an entry point where the program starts to be executed. It seems that for Genome that there are many entry points...
Impressed because of the relentless energy he pours in to his ventures and their success rate, annoyed because of his tendency to take credit and self-aggrandise at every opportunity and intrigued because I wonder where it will all lead.
"""Venter: Well, the goal is multifold. We have to start by creating minimal cells. A human cell is too complex -- we have no idea how any human cell works. We don't even know how the simplest bacterial cell works."""
Do we have no idea how a cell works? I know we understand the anatomy but I had no idea we hadn't moved beyond that? Is this some kind of satire/joke or is this where the state of the science is at?
Keep in mind that this doesn't mean we're completely clueless about how the cell works, just that there's still a lot of work to do.
Someone please correct me if I am wrong.